Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · IEX Real-Time Price · USD
6.21
-0.37 (-5.62%)
At close: Apr 12, 2024, 4:00 PM
6.24
+0.03 (0.48%)
After-hours: Apr 12, 2024, 7:59 PM EDT

Editas Medicine Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Editas Medicine stock have an average target of 14.27, with a low estimate of 8.00 and a high estimate of 20. The average target predicts an increase of 129.79% from the current stock price of 6.21.

Analyst Consensus: Buy
Target Low Average Median High
Price $8.00 $14.27 $14 $20
Change +28.82% +129.79% +125.44% +222.06%
* Price targets were last updated on Feb 29, 2024.

Analyst Ratings

The average analyst rating for EDIT stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Nov '23Dec '23Jan '24Feb '24Mar '24Apr '24
Strong Buy 444444
Buy 433222
Hold 866666
Sell 111000
Strong Sell 000000
Total 171414121212

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Strong Buy
Maintains
$11$16
Strong Buy Maintains $11$16 +157.65% Feb 29, 2024
Barclays
Barclays
Hold
Maintains
$10$11
Hold Maintains $10$11 +77.13% Feb 29, 2024
JP Morgan
JP Morgan
Hold
Maintains
$8$9
Hold Maintains $8$9 +44.93% Feb 27, 2024
Truist Securities
Truist Securities
Strong Buy
Maintains
$15$20
Strong Buy Maintains $15$20 +222.06% Dec 12, 2023
Citigroup
Citigroup
Strong Buy
Upgrades
$11
Strong Buy Upgrades $11 +77.13% Oct 24, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
37.10M
from 78.12M
Decreased by -52.51%
Revenue Next Year
29.58M
from 37.10M
Decreased by -20.27%
EPS This Year
-2.70
from -2.02
EPS Next Year
-2.73
from -2.70
Year 2019202020212022202320242025202620272028
Revenue
20.53M90.73M25.54M19.71M78.12M37.10M29.58M77.36M224.76M307.10M
Revenue Growth
-35.71%341.93%-71.85%-22.83%296.32%-52.51%-20.27%161.52%190.55%36.63%
EPS
-2.68-1.98-2.85-3.21-2.02-2.70-2.73-2.87-1.70-1.41
EPS Growth
----------
No. Analysts -----20181365
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 82.6M 70.1M 254.1M 1.0B 1.2B
Avg 37.1M 29.6M 77.4M 224.8M 307.1M
Low n/a n/a 14.7M 24.5M 24.5M

Revenue Growth

Revenue Growth 20242025202620272028
High
5.8%
89.1%
759.2%
1,213.4%
432.6%
Avg
-52.5%
-20.3%
161.5%
190.6%
36.6%
Low - -
-50.3%
-68.3%
-89.1%

EPS Forecast

EPS 20242025202620272028
High -1.93 -1.80 -1.49 -0.96 -0.47
Avg -2.70 -2.73 -2.87 -1.70 -1.41
Low -3.76 -4.42 -4.54 -2.61 -2.35

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.